| [November 12, 2008] |
 |
This Essential Nanoparticle Drug Delivery Report is Now Available
DUBLIN, Ireland --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/d40ce7/nanoparticle_drug) has announced the addition of the "Nanoparticle Drug Delivery" report to their offering.
Advances in nanotechnology that enable drugs to be delivered in ways that preserve their efficacy and to precise therapeutic targets are creating a host of opportunities for drug developers. A variety of nanostructures are being investigated as functional drug carriers for a wide range of therapies, most notably cardiovascular medicine, autoimmune diseases, and cancer. While the concept of nanoparticles in drug delivery is not new, the number of research programs and active drug development projects has escalated as funding to nanotechnology developers has increased. The result is the emergence of a host of novel nanotechnologies tailored to meet the physicochemical requirements of drug developers. Nanoparticles have already improved the availability and efficacy of some drugs, and the capabilities that evolving technologies possess will leads to a dramatic increase in the number of therapies delivered via nanoparticles
The study presents qualitative and quantitative data and information on key demand factors and trends:
-- Nanoparticle Technology Competitive Assessment
-- Nanoparticle Drug Development Factors
-- Near-Term Nano-Drug Disease Therapies
-- Nanoparticle Technology Commercialization Issues
-- Technology-driven Performance Factors
-- Opportunity Assessment and Factors Limiting Growth
-- Drug Design and Development Factors
-- Sector Participant Profiles
Key Topics Covered:
Executive Summary
Engineered Drug Delivery Market Overview
-- Market Dynamics
-- Competitive Landscape
-- Demand Drivers
-- Factors Limiting Growth
Nanoparticle Design & Technology Factors
-- Drug Solubility
-- Dosage Forms
-- Pharmacokinetics
-- Bioavailability
Commercial Nanoparticle Platform Assessment
-- Mucoadhesive Nanospheres
-- Composite Nanoshells
-- Magnetic Nanoparticles
-- Quantum Dots
-- Optical Activation
-- Emerging Nanoparticle Delivery Technologies
Nanoparticle Drug Delivery Market Drivers
-- Safety
-- Targeted Drug Delivery
-- Funding Programs
-- Patient/Consumer Sentiment
-- Enhanced Compliance
Near-term Nanoparticle Delivery Therapeutics
-- Autoimmune Diseases
-- Cardiovascular Medicine
-- Cancer Therapy
-- Musculoskeletal
-- Vaccines
-- Emerging Markets
-- Existing/Approved Drugs
-- New Drug Discovery
-- DNA-based Therapies
Market Factors
-- Government Regulations
-- Health Standards Organizations
-- Growth of Self-Administration
-- Managed Care Initiatives
-- Shifting Patient Demographics
-- Patent Expiry and Generics
-- Rx-to-OTC Switching
Nanoparticle Drug Delivery - Company Profile
For more information visit http://www.researchandmarkets.com/research/d40ce7/nanoparticle_drug.
[ Back To TMCnet.com's Homepage ]
|